InterAx and Alveus collaborate on small-molecule metabolic treatment
The agreement includes an upfront payment, with potential future payments linked to development, regulatory, and commercial milestones.
Drug Development
Agenus and Zydus complete $141m BOT+BAL immunotherapy collaboration deal
Fortress Biotech receives FDA approval for Zycubo to treat Menkes disease
JPM26: SciNeuro and Novartis sign global licensing deal for Alzheimer’s antibody
Atara receives FDA complete response letter for Ebvallo BLA application
MediLink and Roche announce exclusive licensing agreement for YL201
Takeda and Halozyme sign global agreement for Enhanze technology
Santhera grants Agamree rights to Nxera for DMD
